SICHUAN HEZONG MEDICINE EASY-TO-BUY PHARMACEUTICAL CO., LTD.

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.

300937

CNE100004CV9

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 27/06/2024 BST			5-day change	1st Jan Change
20.38 ^CNY	+0.25%		-3.78%	-35.20%

05-06	Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Approves Cash Dividend for 2023	CI
04-24	Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Approves Cash Dividend for 2023

May 06, 2024 at 08:32 pm

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. announced that at the Annual General Meeting of 2023 on 30 April 2024, approved Cash dividend per 10 shares (tax included) of CNY 2.20000000 for 2023.

Latest news about Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Approves Cash Dividend for 2023	05-06	CI
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24	CI
Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical Co., Ltd. Proposes Final Dividend for 2023	04-09	CI
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-09	CI
Certain A Shares of Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 25-JAN-2024.	01-24	CI
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	22/08/23	CI
Sichuan Zhonghuisheng Traditional Chinese Medicine Material partnership (limited partnership) agreed to acquire 80% stake in Sichuan Hezong Traditional Chinese Medicine Pieces Co., Ltd. from Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. for CNY 6.7 million.	26/07/23	CI
Sichuan Hezong Medicine Co., Ltd. Announces Cash Dividend on A Shares for 2022, Payable 22 May 2023	16/05/23	CI
Sichuan Hezong Medicine Co., Ltd. Approves Cash Dividend for 2022	12/05/23	CI
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23	CI
Hezong Medicine Easy-to-Buy Pharma to Apply For Up to 500 Million Yuan Bank Loan	21/04/23	MT
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	20/04/23	CI
Li Yuemin agreed to acquire additional 58.02% stake in Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. from Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. for CNY 15.4 million.	26/12/22	CI
Hezong Medicine Chairman Boosts Stake to 55% After 230 Million Yuan Deal	14/12/22	MT
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	23/10/22	CI
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/08/22	CI
Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical Co., Ltd. Announces Management Changes	19/07/22	CI
Wuxu Data announced that it has received $0.3 million in funding from Sichuan Shenniao Century Technology Co., Ltd. and Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. and another investor	09/05/22	CI
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	21/04/22	CI
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	17/04/22	CI
Certain A Shares of Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 25-JAN-2022.	24/01/22	CI
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	25/10/21	CI
Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	19/08/21	CI
Sichuan Hezong Medicine Easy to buy Pharmaceutical : to List 1.25% Stake as IPO Lockup Ends; Shares Slump 7%	26/07/21	MT
Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical Co., Ltd. Approves Cash Dividend for 2020	10/05/21	CI

Chart Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.

Duration

Period

Chart Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.

More charts

Company Profile

SICHUAN HZ-YEG MEDICAL Co Ltd is a China-based company mainly engaged in the pharmaceutical distribution industry. The Company mainly provides comprehensive medical circulation services in the out-of-hospital market. The Company's products cover western medicines, Chinese patent medicines, Chinese herbal medicines and Chinese medicinal materials, food and health food, medical equipment and non-medicinal products.

Sector

Pharmaceuticals

Calendar

21/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
SICHUAN HEZONG MEDICINE EASY-TO-BUY PHARMACEUTICAL CO., LTD.	-35.20%	268M
CARDINAL HEALTH, INC.	-2.46%	23.95B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+14.23%	8.7B
SINOPHARM GROUP CO. LTD.	+1.47%	8.29B
HUADONG MEDICINE CO., LTD	-32.92%	6.7B
H. LUNDBECK A/S	+18.62%	5.38B
GALENICA AG	+1.10%	4.08B
EBOS GROUP LIMITED	-9.24%	3.79B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	-10.20%	3.3B
MEDIPAL HOLDINGS CORPORATION	+7.11%	3.19B